REMUS PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Remus Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.22₹ -10
As on Sep 16, 2025, 2:16 PM IST
Remus Pharmaceuticals Price Performance
Today's LowToday's High
₹775.00₹838.80
₹810.00
52 Weeks' Low52 Weeks' High
₹813.00₹1,416.45
₹810.00
Open Price
₹775.00
Prev. Close
₹820.00
Volume
1,200
Over the last 5 years, the share price of Remus Pharmaceuticals has gained 29.25% CAGR. Over the past year, the corresponding return has been -34.48%.
Remus Pharmaceuticals’s current P/E of 12.70x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Remus Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Remus Pharmaceuticals | 0.01 | -9.64 | -11.72 | -16.98 | -33.03 | 54.48 | 29.81 |
| Sun Pharmaceutical Industries | 0.96 | -1.57 | -4.65 | -5.71 | -13.74 | 22.79 | 25.39 |
| Divi's Laboratories | 1.10 | -1.56 | -9.26 | 7.01 | 10.75 | 19.30 | 13.34 |
| Cipla | 0.34 | -0.54 | 1.95 | 4.30 | -6.18 | 14.27 | 15.65 |
| Torrent Pharmaceuticals | -2.87 | -3.09 | 8.02 | 15.40 | 2.45 | 33.76 | 20.01 |
| Dr. Reddy's Laboratories | 1.23 | 3.52 | -2.94 | 13.60 | -1.67 | 17.03 | 7.15 |
| Mankind Pharma | -0.55 | 4.15 | 8.65 | 18.61 | 4.83 | 21.88 | 12.60 |
| Zydus Lifesciences | 0.12 | 5.10 | 6.40 | 16.14 | -7.08 | 42.10 | 21.70 |
| Lupin | 4.57 | 3.98 | 1.78 | 2.75 | -9.11 | 47.94 | 14.75 |
| Abbott India | 1.39 | -4.71 | -1.96 | 2.91 | 6.56 | 20.96 | 13.45 |
| Alkem Laboratories | 2.74 | 2.54 | 12.61 | 13.78 | -13.77 | 19.90 | 14.19 |
| Aurobindo Pharma | 4.94 | 0.57 | -4.36 | -1.46 | -29.96 | 27.14 | 5.65 |
| Glenmark Pharmaceuticals | -1.70 | 5.40 | 23.58 | 45.52 | 19.46 | 77.51 | 33.01 |
| Laurus Labs | -0.84 | 3.36 | 31.53 | 53.90 | 77.33 | 20.08 | 27.16 |
| Biocon | -1.18 | -1.13 | 0.83 | 8.09 | -7.92 | 7.34 | -3.86 |
| Anthem Biosciences | 2.88 | 5.23 | 15.36 | 15.36 | 15.36 | 4.88 | 2.90 |
| GlaxoSmithKline Pharmaceuticals | -2.29 | -1.36 | -18.14 | 2.33 | -2.57 | 24.40 | 9.23 |
| Cohance Lifesciences | -3.45 | 9.73 | -0.89 | -13.26 | -16.39 | 28.87 | 21.39 |
| Gland Pharma | 6.28 | 3.48 | 15.29 | 31.15 | 9.44 | -3.80 | 2.33 |
| Ipca Laboratories | -1.12 | -5.67 | -4.20 | -0.94 | -10.59 | 14.87 | 3.43 |
Over the last one year, Remus Pharmaceuticals has declined 33.03% compared to peers like Sun Pharmaceutical Industries (-13.74%), Divi's Laboratories (10.75%), Cipla (-6.18%). From a 5 year perspective, Remus Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.39%) and Divi's Laboratories (13.34%).
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 837.58 | 837.46 |
| 10 | 864.84 | 853.29 |
| 20 | 890.18 | 872.07 |
| 50 | 904.65 | 901.35 |
| 100 | 944.25 | 939.73 |
| 200 | 1,027.79 | 982.54 |
Remus Pharmaceuticals Share Holding Pattern
In the latest quarter, Remus Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 0.79%, FII holding rose to 5.03%, and public shareholding moved down to 23.31% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Remus Pharmaceuticals Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Remus Pharmaceuticals fact sheet for more information
About Remus Pharmaceuticals
Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 79.16 Cr. and Equity Capital is Rs. 5.89 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ahmedabad Gujarat 380054
- Contact
Management
- Mr. Swapnil Jatinbhai ShahChairman & Wholetime Director
- Mr. Arpit Deepakkumar ShahManaging Director
- Mrs. Anar Swapnil ShahWhole Time Director
- Ms. Roma Vinodbhai ShahWhole Time Director
- Mr. Balwant PurohitInd. Non-Executive Director
- Mrs. Sanjana Sanjeev ShahInd. Non-Executive Director
- Mr. Vishrut Chandramauli PathakInd. Non-Executive Director
FAQs on Remus Pharmaceuticals Share Price
What is the share price of Remus Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Remus Pharmaceuticals is ₹810.00 as on Sep 16, 2025.
What kind of stock is Remus Pharmaceuticals?
The Remus Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Remus Pharmaceuticals?
The market cap of Remus Pharmaceuticals is ₹975.72 Cr as on Sep 16, 2025.
What are today's High and Low prices of Remus Pharmaceuticals?
Today’s highest and lowest price of Remus Pharmaceuticals are ₹838.80 and ₹775.00.
What are the 52 Week High and 52 Week Low of Remus Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Remus Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Remus Pharmaceuticals is ₹1,416.45 and 52-week low of Remus Pharmaceuticals is ₹813.00 as on Sep 16, 2025.
How has the Remus Pharmaceuticals performed historically in terms of returns?
The Remus Pharmaceuticals has shown returns of -1.22% over the past day, -11.6% for the past month, -13.64% over 3 months, -34.48% over 1 year, 53.35% across 3 years, and 29.25% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Remus Pharmaceuticals?
P/E ratio of and PB ratio of Remus Pharmaceuticals are 12.70 and 3.81 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data